Kala Pharmaceuticals, Inc. Recorded Big Gain
Tue, Dec 05, 2023 at 07:44 PM
Kala Pharmaceuticals, Inc. (KALA:NASDAQ) soared at $8.91, representing a gain of 37.3%. On Tue, Dec 05, 2023, KALA:NASDAQ touched a New 2-Week High of $8.91. The stock appeared on our News Catalysts scanner on Mon, Nov 13, 2023 at 12:32 PM in the 'INVESTOR UPDATE' category. From Tue, Nov 21, 2023, the stock recorded 55.56% Up Days and 60.00% Green Days
About Kala Pharmaceuticals, Inc. (KALA:NASDAQ)
Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary nanoparticle-based Mucus Penetrating Particles technology, with focus on the treatment of eye diseases.
Top 10 Gainers:
- Vinco Ventures Inc. (BBIG:NASDAQ), 127.27%
- Chanson International Holding (CHSN:NASDAQ), 64.14%
- Sphere 3D Corp. (ANY:NASDAQ), 62.62%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 56.45%
- ChinaNet Online Holdings, Inc. (CNET:NASDAQ), 52.86%
- Janover Inc. (JNVR:NASDAQ), 38.46%
- Kala Pharmaceuticals, Inc. (KALA:NASDAQ), 37.29%
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 33.33%
- Mercurity Fintech Holding Inc. (MFH:NASDAQ), 33.05%
- Athersys, Inc. (ATHX:NASDAQ), 32.17%